Previous 10 | Next 10 |
Editor's Note: The summary bullets for this article were chosen by Seeking Alpha Read more ...
Pacira Pharmaceuticals ( PCRX ) Q1 results : Revenues: $91.3M (+22.4%); Exparel sales: $90.6M (22.4%); Royalty revenue: $0.4M (+33.3%). More news on: Pacira BioSciences, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...
Pacira Pharmaceuticals (NASDAQ: PCRX ): Q1 Non-GAAP EPS of $0.22 misses by $0.04 ; GAAP EPS of -$0.07. More news on: Pacira BioSciences, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
-- EXPAREL® net product sales of $90.6 million up 22.4 percent over prior year first quarter -- -- MyoScience acquisition advances leadership in non-opioid pain management; corporate name change to Pacira BioSciences reflects expanding product portfolio -- -- Conference ...
Staffing 360 Solutions (NASDAQ: STAF ) +22% on Q1 earnings . More news on: Staffing 360 Solutions, Inc., Nu Skin Enterprises, Inc., Enphase Energy, Inc., Stocks on the move, Read more ...
Source: Shutterstock The stock market has continued to edge higher and the two major indexes, the Nasdaq ( QQQ ) and S&P 500 ( SPY ), touched the all-time high milestone last week. The steady gain reflects a diminishing concern relating to the pace of a global economic slowdown, as m...
We think Heron ( HRTX ) has a very good chance of approval by the FDA by the April 30, 2019 due date for its non-opioid pain med HTX-011. This would be good for society in our fight against the opioid crisis. Furthermore, it could be rewarding for investors too, since this derisking event if t...
PARSIPPANY, N.J., April 25, 2019 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its first quarter financial results before the open of the U.S. markets on Thursday, May 2, 2019. Following the release, the company will host a live conference ca...
Safety First: NASCAR driver Johanna Long and her helmet (Credit: Gearheads ) Bulletproof Investing: Week 72 Performance Each week since the beginning of June 2017, I have presented at least two hedged portfolios created by Portfolio Armor to my Bulletproof Investing subscribers. This is...
News, Short Squeeze, Breakout and More Instantly...
Pacira BioSciences Inc. Company Name:
PCRX Stock Symbol:
NASDAQ Market:
Pacira BioSciences Inc. Website:
-- Proposed Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment System Rule extends separate payment from ambulatory surgical centers to include the hospital outpatient environment – -- Rule implements the NOPAIN Act, signed into law as part of the Cons...
A look at the top 10 most actives in the United States Ocean Power Technologies Inc. (OPTT) rose 86.1% to $0.514 on volume of 587,366,807 shares NVIDIA Corporation (NVDA) fell 1.3% to $122.67 on volume of 214,038,378 shares Tesla Inc. (TSLA) rose 10.2% to $231.26 on volume of 201,850,947 ...
2024-07-02 14:00:06 ET Oren Livnat from H.C. Wainwright issued a price target of $57.00 for PCRX on 2024-07-02 12:36:00. The adjusted price target was set to $57.00. At the time of the announcement, PCRX was trading at $21.91. The overall price target consensus is at $48...